Birdwatch Note
2024-05-03 23:44:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
引用している修飾ウリジンががんを促進、というのは既にファクトチェックされた誤情報です。下記で解説されていますが https://healthfeedback.org/claimreview/modified-rna-covid19-vaccines-arent-linked-to-cancer-development/ この話を主張した総説の主張は以下の研究に全面的に依存していますが https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.983000/full この引用された研究が示したのは、修飾していないウリジンが最も効果的だという事だけで、修飾したウリジンが生理食塩水より逆効果というような事を示した結果は存在しません。例えば腫瘍のサイズ、生存率では、下記の図のC、Fにあるように、最も悪いのは生理食塩水(PBS)で修飾されたウリジンの実験群(NEO LNP 100% m1ψ)は有意に生理食塩水より結果がよいです。 https://www.frontiersin.org/files/Articles/983000/fimmu-13-983000-HTML/image_m/fimmu-13-983000-g008.jpg
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1786438702094528890
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1786542400380559378
- noteId - 1786542400380559378
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1714779875260
- tweetId - 1786438702094528890
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 引用している修飾ウリジンががんを促進、というのは既にファクトチェックされた誤情報です。下記で解説されていますが https://healthfeedback.org/claimreview/modified-rna-covid19-vaccines-arent-linked-to-cancer-development/ この話を主張した総説の主張は以下の研究に全面的に依存していますが https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.983000/full この引用された研究が示したのは、修飾していないウリジンが最も効果的だという事だけで、修飾したウリジンが生理食塩水より逆効果というような事を示した結果は存在しません。例えば腫瘍のサイズ、生存率では、下記の図のC、Fにあるように、最も悪いのは生理食塩水(PBS)で修飾されたウリジンの実験群(NEO LNP 100% m1ψ)は有意に生理食塩水より結果がよいです。 https://www.frontiersin.org/files/Articles/983000/fimmu-13-983000-HTML/image_m/fimmu-13-983000-g008.jpg
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-05-03 23:44:35 UTC (1714779875260) |
2024-05-04 06:16:06 UTC (1714803366430) |
CURRENTLY_RATED_HELPFUL | 2024-05-04 06:16:06 UTC (1714803366430) |
CURRENTLY_RATED_HELPFUL | 2024-05-04 06:16:06 UTC (1714803366430) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-05-03 20:27:54 -0500 | Rating Details | |
2024-05-03 20:03:27 -0500 | Rating Details | |
2024-05-03 20:01:51 -0500 | Rating Details | |
2024-05-03 20:00:05 -0500 | Rating Details | |
2024-05-03 19:54:41 -0500 | Rating Details | |
2024-05-03 19:52:32 -0500 | Rating Details | |
2024-05-03 19:10:38 -0500 | Rating Details | |
2024-05-03 18:55:32 -0500 | Rating Details | |
2024-05-03 18:54:33 -0500 | Rating Details | |
2024-05-03 18:47:12 -0500 | Rating Details | |
2024-05-05 05:42:19 -0500 | Rating Details | |
2024-05-05 00:43:40 -0500 | Rating Details | |
2024-05-04 18:31:51 -0500 | Rating Details | |
2024-05-04 13:01:26 -0500 | Rating Details | |
2024-05-04 08:52:09 -0500 | Rating Details | |
2024-05-04 08:22:26 -0500 | Rating Details | |
2024-05-04 08:07:24 -0500 | Rating Details | |
2024-05-04 07:57:55 -0500 | Rating Details | |
2024-05-04 07:57:43 -0500 | Rating Details | |
2024-05-04 00:15:47 -0500 | Rating Details | |
2024-05-04 00:03:39 -0500 | Rating Details | |
2024-05-03 23:18:23 -0500 | Rating Details | |
2024-05-03 22:39:20 -0500 | Rating Details | |
2024-05-03 22:29:51 -0500 | Rating Details | |
2024-05-03 21:10:42 -0500 | Rating Details | |
2024-05-03 21:03:36 -0500 | Rating Details | |
2024-05-03 21:02:37 -0500 | Rating Details | |
2024-05-03 21:02:02 -0500 | Rating Details | |
2024-05-03 20:54:55 -0500 | Rating Details | |
2024-05-03 20:49:17 -0500 | Rating Details | |
2024-05-03 20:45:27 -0500 | Rating Details | |
2024-05-03 20:26:02 -0500 | Rating Details | |
2024-05-03 20:23:11 -0500 | Rating Details | |
2024-05-03 20:13:50 -0500 | Rating Details | |
2024-05-03 20:09:51 -0500 | Rating Details | |
2024-05-03 19:56:16 -0500 | Rating Details | |
2024-05-03 19:31:44 -0500 | Rating Details | |
2024-05-03 19:28:41 -0500 | Rating Details | |
2024-05-03 18:54:25 -0500 | Rating Details | |
2024-05-03 18:45:14 -0500 | Rating Details | |
2024-05-04 17:05:48 -0500 | Rating Details | |
2024-05-04 14:48:46 -0500 | Rating Details | |
2024-05-04 12:03:20 -0500 | Rating Details | |
2024-05-04 09:32:44 -0500 | Rating Details | |
2024-05-04 09:24:04 -0500 | Rating Details | |
2024-05-04 09:20:14 -0500 | Rating Details | |
2024-05-04 09:14:59 -0500 | Rating Details | |
2024-05-04 08:29:10 -0500 | Rating Details | |
2024-05-04 08:19:18 -0500 | Rating Details | |
2024-05-04 03:43:55 -0500 | Rating Details | |
2024-05-03 23:49:15 -0500 | Rating Details | |
2024-05-03 23:20:35 -0500 | Rating Details | |
2024-05-03 22:59:48 -0500 | Rating Details | |
2024-05-03 21:02:54 -0500 | Rating Details | |
2024-05-05 06:14:36 -0500 | Rating Details | |
2024-05-09 10:02:44 -0500 | Rating Details | |
2024-05-06 03:50:55 -0500 | Rating Details | |
2024-05-05 16:08:09 -0500 | Rating Details | |
2024-05-05 02:59:59 -0500 | Rating Details | |
2024-05-04 12:27:34 -0500 | Rating Details | |
2024-05-04 12:10:58 -0500 | Rating Details | |
2024-05-04 10:13:54 -0500 | Rating Details | |
2024-05-04 08:26:11 -0500 | Rating Details | |
2024-05-04 08:21:06 -0500 | Rating Details | |
2024-05-04 07:59:11 -0500 | Rating Details | |
2024-05-04 03:06:26 -0500 | Rating Details | |
2024-05-04 02:14:01 -0500 | Rating Details | |
2024-05-04 01:16:40 -0500 | Rating Details | |
2024-05-04 00:46:19 -0500 | Rating Details | |
2024-05-04 00:35:30 -0500 | Rating Details | |
2024-05-03 23:38:41 -0500 | Rating Details | |
2024-05-03 23:35:05 -0500 | Rating Details | |
2024-05-03 22:23:57 -0500 | Rating Details | |
2024-05-03 21:48:43 -0500 | Rating Details | |
2024-05-03 21:06:44 -0500 | Rating Details | |
2024-05-03 20:23:31 -0500 | Rating Details | |
2024-05-03 19:54:26 -0500 | Rating Details | |
2024-05-03 19:44:16 -0500 | Rating Details | |
2024-05-03 18:47:14 -0500 | Rating Details | |
2024-05-05 13:48:20 -0500 | Rating Details | |
2024-05-04 19:35:17 -0500 | Rating Details | |
2024-05-04 18:16:59 -0500 | Rating Details | |
2024-05-04 10:16:32 -0500 | Rating Details | |
2024-05-04 06:30:42 -0500 | Rating Details | |
2024-05-04 00:46:44 -0500 | Rating Details | |
2024-05-04 00:12:35 -0500 | Rating Details | |
2024-05-03 23:38:22 -0500 | Rating Details | |
2024-05-03 23:37:19 -0500 | Rating Details | |
2024-05-03 23:32:07 -0500 | Rating Details | |
2024-05-03 23:21:01 -0500 | Rating Details | |
2024-05-03 21:45:05 -0500 | Rating Details | |
2024-05-03 21:05:52 -0500 | Rating Details | |
2024-05-03 20:39:12 -0500 | Rating Details | |
2024-05-03 20:10:22 -0500 | Rating Details | |
2024-05-03 20:01:30 -0500 | Rating Details | |
2024-05-03 20:00:51 -0500 | Rating Details | |
2024-05-03 19:57:13 -0500 | Rating Details | |
2024-05-03 19:54:10 -0500 | Rating Details | |
2024-05-03 19:26:16 -0500 | Rating Details | |
2024-05-03 19:01:24 -0500 | Rating Details | |
2024-05-03 18:51:10 -0500 | Rating Details | |
2024-05-04 12:10:10 -0500 | Rating Details | |
2024-05-03 23:56:53 -0500 | Rating Details | |
2024-05-04 23:21:41 -0500 | Rating Details | |
2024-05-04 07:59:14 -0500 | Rating Details | |
2024-05-04 03:42:15 -0500 | Rating Details | |
2024-05-03 22:55:48 -0500 | Rating Details | |
2024-05-03 20:01:58 -0500 | Rating Details | |
2024-05-04 12:46:00 -0500 | Rating Details | |
2024-06-14 00:51:43 -0500 | Rating Details |